Purple Loosestrife (Lythrum salicaria): Benefits, Dosage, Safety & Evidence

Frequently asked questions

How does Purple Loosestrife work as an astringent?

Purple Loosestrife contains high concentrations of tannins and ellagitannins, which are polyphenolic compounds that bind to proteins. When applied to mucous membranes or wounds, these tannins precipitate surface proteins, creating a protective layer that reduces secretions, tightens tissues, and helps stop bleeding. This astringent action explains its traditional use for diarrhea and wound healing. The flavonoids also contribute anti-inflammatory effects. Evidence level: C (primarily traditional and in vitro data).

Does Purple Loosestrife interact with any medications?

Purple Loosestrife's high tannin content may reduce the absorption of certain medications when taken orally. Tannins can bind to alkaloids and some pharmaceutical compounds, potentially decreasing their effectiveness. This includes medications taken for diabetes, as Purple Loosestrife may affect blood sugar levels. Those on antidiabetic drugs, iron supplements, or medications with narrow therapeutic windows should consult a healthcare provider before use. Evidence level: C.

What is the recommended dosage for Purple Loosestrife?

The typical adult dosage for Purple Loosestrife is 2–4 grams of dried herb prepared as a tea, or 2–4 mL of tincture taken three times daily. Due to its strong astringent properties, it's best to start with lower doses and assess tolerance. Extended use at higher doses may cause constipation. This herb should not be used for prolonged periods without professional guidance. Evidence level: C (based on traditional use and pharmacopoeia standards).

Is Purple Loosestrife safe during pregnancy and breastfeeding?

Purple Loosestrife is considered unsafe during pregnancy and should be avoided. The herb's strong astringent properties and potential uterine effects may pose risks during pregnancy. There is insufficient safety data for breastfeeding, so use is not recommended during lactation either. Women who are pregnant, trying to conceive, or nursing should consult a qualified healthcare provider before using any herbal preparations containing Purple Loosestrife. Evidence level: C.

What is Purple Loosestrife used for in herbal medicine?

Purple Loosestrife has been used traditionally in European and North American herbal medicine primarily for diarrhea, dysentery, and wound healing. Its powerful astringent properties make it useful for conditions involving excess secretions or bleeding. Historical European use also included typhoid fever management. Some folk traditions employ it for blood sugar support, though clinical evidence is limited. The herb is typically prepared as a tea, tincture, or applied topically as a wash. Evidence level: C.

PubMed-compiled information sheet

This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.

Compiled from 30 PubMed articles · model: gemma4:31b

Summary

Purple loosestrife (Lythrum salicaria) is a herbaceous perennial plant used in European traditional medicine [PMID:25985768] and studied for its antioxidant and therapeutic potential [PMID:40427455, PMID:41012436].

Background

Lythrum salicaria is a herbaceous perennial plant belonging to the Lythraceae family [PMID:25985768]. It is native to Europe and has become an invasive species in North American wetlands [PMID:35347196, PMID:40481807].

Traditional uses

It has been used for centuries in European traditional medicine [PMID:25985768]. Specifically, flowering parts and branch tips have been used internally as decoctions or extracts to treat diarrhea, hemorrhoids, eczema, and chronic intestinal catarrhs, and externally for gums, venous insufficiency, and varicose veins [PMID:20554008]. It has also been used as an astringent to stop bleeding [PMID:20554008].

Active compounds

The plant contains phenolic compounds, including vitexin, orientin, isovitexin, isoorientin, phenolic acids, and tannins such as vescalagin and pedunculagin [PMID:11302202]. It also contains phenolic glucosides, including 6'-(p-methoxyphenyl)gallate-7-O-β-D-glucopyranoside and 6'-ethyl-p-hydroxyphenylethanol-β-D-glucopyranoside [PMID:39701801]. Additionally, a high molecular mass polysaccharide-polyphenolic conjugate consisting of 74% carbohydrates (high GalA, Rha, Gal, and Ara content) and 17% phenolics has been isolated [PMID:22829057].

Mechanism of action

Extracts demonstrate antioxidant capacity via FRAP, DPPH, NO, and H2O2 scavenging assays [PMID:40427455]. A polysaccharide-polyphenolic conjugate has shown antitussive and bronchodilatory effects, including the reduction of cough efforts and influence on airways smooth muscle reactivity [PMID:22829057].

Clinical evidence

Evidence DBurn wounds

Hydromethanolic extracts of L. salicaria showed burn wound healing activity in second-degree burn wounds in rats [PMID:27701123]

Evidence DDiabetes Mellitus and PCOS

Ethanol extract was evaluated for its potential to mitigate oxidative stress, inflammation, and metabolic/hormonal imbalances in experimental rat models [PMID:40427455]

Evidence DAcute Murine Campylobacteriosis

A combination of extracts including L. salicaria alleviated diarrheal symptoms in diseased mice on day 6 post-infection [PMID:37896170]

Evidence DCough and Bronchoconstriction

A polysaccharide-polyphenolic conjugate reduced cough efforts and showed significant bronchodilatory effects in animal models [PMID:22829057]

Evidence DBreast Cancer (MCF7 cells)

Silver nanoparticles synthesized using L. salicaria extract showed significant cytotoxicity against MCF7 cells (IC50 of 113 μg mL-1) [PMID:39589605]

Safety & adverse effects

In vivo toxicity was evaluated using a Drosophila melanogaster-based model system [PMID:41012436]. In rabbit nutrition studies, high levels of L. salicaria supplementation (0.4%) resulted in lower crude protein and ether extract digestibility compared to control groups [PMID:26354442].

Evidence summary

The current evidence is primarily based on in vitro studies, animal models (rats, mice, rabbits), and traditional use reviews. There are no human clinical trials provided in the source material.

PubMed sources

1.PMID: 36994381 (2023) — Greater flowering and response to flooding in Lythrum virgatum than L. salicaria (purple loosestrife). · AoB PLANTS
2.PMID: 35347196 (2022) — Mapping the purple menace: spatiotemporal distribution of purple loosestrife (Lythrum salicaria) along roadsides in northern New York State. · Scientific reports
3.PMID: 25985768 (2015) — Lythrum salicaria L.-Underestimated medicinal plant from European traditional medicine. A review. · Journal of ethnopharmacology
4.PMID: 40427455 (2025) — Therapeutic Potential of Lythrum salicaria L. Ethanol Extract in Experimental Rat Models of Streptozotocin-Induced Diabetes Mellitus and Letrozole-Induced Polycystic Ovary Syndrome. · Antioxidants (Basel, Switzerland)
5.PMID: 30455215 (2018) — Bookkeeping of insect herbivory trends in herbarium specimens of purple loosestrife (Lythrum salicaria).

Purple Loosestrife

Sources & Citations

Calculate a safe dose of Purple Loosestrife

Ipomoea Batatas Leaf

Terminalia catappa

Jatropha gossypiifolia

Frequently asked questions

Summary

Background

Traditional uses

Active compounds

Mechanism of action

Clinical evidence

Safety & adverse effects

Evidence summary

PubMed sources

Government sources

Purple Loosestrife

Sources & Citations

Calculate a safe dose of Purple Loosestrife

Related Herbs

Ipomoea Batatas Leaf

Terminalia catappa

Jatropha gossypiifolia

Frequently asked questions

Summary

Background

Traditional uses

Active compounds

Mechanism of action

Clinical evidence

Safety & adverse effects

Evidence summary

PubMed sources

Government sources